Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Joint status in Spanish haemophilia B patients assessed using the Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) score.

Jiménez-Yuste V, Álvarez-Román MT, Martín-Salces M, De la Corte-Rodríguez H, Altisent C, Parra R, Núñez R, Pérez R, García-Candel F, Bonanad S, Querol F, Alonso N, Fernández-Mosteirín N, López-Ansoar E, García-Frade LJ, Bermejo N, Pérez-González N, Gutiérrez-Pimentel MJ, Martinoli C, Fernández-Arias I, Kim HK.

Haemophilia. 2018 Nov 16. doi: 10.1111/hae.13628. [Epub ahead of print]

PMID:
30444298
2.

Polymorphisms in receptors involved in opsonic and non-opsonic phagocytosis and the risk of infection in oncohematological patients.

Herrero-Sánchez MC, Angomás EB, de Ramón C, Tellería JJ, Corchete LA, Alonso S, Ramos MDC, Peñarrubia MJ, Márquez S, Fernández N, García Frade LJ, Sánchez Crespo M.

Infect Immun. 2018 Oct 1. pii: IAI.00709-18. doi: 10.1128/IAI.00709-18. [Epub ahead of print]

PMID:
30275011
3.

Efficacy and safety of eltrombopag in persistent and newly diagnosed ITP in clinical practice.

González-López TJ, Fernández-Fuertes F, Hernández-Rivas JA, Sánchez-González B, Martínez-Robles V, Alvarez-Román MT, Pérez-Rus G, Pascual C, Bernat S, Arrieta-Cerdán E, Aguilar C, Bárez A, Peñarrubia MJ, Olivera P, Fernández-Rodríguez A, de Cabo E, García-Frade LJ, González-Porras JR.

Int J Hematol. 2017 Oct;106(4):508-516. doi: 10.1007/s12185-017-2275-4. Epub 2017 Jun 30.

PMID:
28667351
4.

Application of a molecular diagnostic algorithm for haemophilia A and B using next-generation sequencing of entire F8, F9 and VWF genes.

Bastida JM, González-Porras JR, Jiménez C, Benito R, Ordoñez GR, Álvarez-Román MT, Fontecha ME, Janusz K, Castillo D, Fisac RM, García-Frade LJ, Aguilar C, Martínez MP, Bermejo N, Herrero S, Balanzategui A, Martin-Antorán JM, Ramos R, Cebeiro MJ, Pardal E, Aguilera C, Pérez-Gutierrez B, Prieto M, Riesco S, Mendoza MC, Benito A, Hortal Benito-Sendin A, Jiménez-Yuste V, Hernández-Rivas JM, García-Sanz R, González-Díaz M, Sarasquete ME.

Thromb Haemost. 2017 Jan 5;117(1):66-74. doi: 10.1160/TH16-05-0375. Epub 2016 Oct 13.

PMID:
27734074
5.

Design and application of a 23-gene panel by next-generation sequencing for inherited coagulation bleeding disorders.

Bastida JM, Del Rey M, Lozano ML, Sarasquete ME, Benito R, Fontecha ME, Fisac R, García-Frade LJ, Aguilar C, Martínez MP, Pardal E, Aguilera C, Pérez B, Ramos R, Cardesa MR, Martin-Antorán JM, Silvestre LA, Cebeira MJ, Bermejo N, Riesco S, Mendoza MC, García-Sanz R, González-Díaz M, Hernández-Rivas JM, González-Porras JR.

Haemophilia. 2016 Jul;22(4):590-7. doi: 10.1111/hae.12908. Epub 2016 Feb 15.

PMID:
26879396
6.

Eltrombopag safety and efficacy for primary chronic immune thrombocytopenia in clinical practice.

González-López TJ, Alvarez-Román MT, Pascual C, Sánchez-González B, Fernández-Fuentes F, Jarque I, Pérez-Rus G, Pérez-Crespo S, Bernat S, Hernández-Rivas JA, Andrade MM, Cortés M, Gómez-Nuñez M, Olivera P, Martínez-Robles V, Fernández-Rodríguez A, Fuertes-Palacio MA, Fernández-Miñano C, de Cabo E, Fisac R, Aguilar C, Bárez A, Peñarrubia MJ, García-Frade LJ, González-Porras JR.

Eur J Haematol. 2016 Sep;97(3):297-302. doi: 10.1111/ejh.12725. Epub 2016 Jan 27.

PMID:
26709028
7.

Safety and efficacy of splenectomy in over 65-yrs-old patients with immune thrombocytopenia.

Gonzalez-Porras JR, Escalante F, Pardal E, Sierra M, Garcia-Frade LJ, Redondo S, Arefi M, Aguilar C, Ortega F, de Cabo E, Fisac RM, Sanz O, Esteban C, Alberca I, Sanchez-Barba M, Santos MT, Fernandez A, Gonzalez-Lopez TJ; Grupo de Trombosis y Hemostasia de Castilla y León.

Eur J Haematol. 2013 Sep;91(3):236-41. doi: 10.1111/ejh.12146. Epub 2013 Jul 7.

PMID:
23679653
8.

Hematologic and cytogenetic response to lenalidomide in de novo acute myeloid leukemia with chromosome 5q deletion.

Peñarrubia MJ, Silvestre LA, Conde J, Cantalapiedra A, Garcia Frade LJ.

Leuk Res. 2009 Jun;33(6):e8-9. doi: 10.1016/j.leukres.2008.11.017. Epub 2009 Jan 24. No abstract available.

PMID:
19168219
9.

[Effect of persistent microvascular obstruction on post-infarction ventricular remodeling following intracoronary bone-marrow cell transplantation: a contrast-enhanced cardiac magnetic resonance study].

Villa A, Tejedor-Viñuela P, Sánchez PL, Tapia C, Arnold R, Gómez-Salvador I, García-Frade LJ, Sánchez A, Fernández-Avilés F, San Román JA.

Rev Esp Cardiol. 2008 Jun;61(6):602-10. Spanish.

10.

Oral anticoagulant treatment: risk factors involved in 500 intracranial hemorrhages.

Cantalapiedra A, Gutierrez O, Tortosa JI, Yañez M, Dueñas M, Fernandez Fontecha E, Peñarrubia MJ, García-Frade LJ.

J Thromb Thrombolysis. 2006 Oct;22(2):113-20.

PMID:
17008977
11.

[Treatment of coagulopathy in severe sepsis].

Gutiérrez Pérez O, Cantalapiedra Díez A, García Frade LJ.

Rev Clin Esp. 2003 May;203(5):240-1. Spanish. No abstract available.

PMID:
12765571
12.

Emphysematous gastritis and severe aplastic anemia.

Gutierrez O, Cantalapiedra A, Tabuyo MI, Del Villar R, Peñarrubia MJ, Sales R, García-Frade LJ.

Hematol J. 2003;4(1):82-4. Review.

PMID:
12692527
13.

[Dyspnea, cough, and pulmonary mass].

Gutiérrez Zufiaurre JL, García Frade LJ, Gutiérrez Pérez O, López Izquierdo R, Del Campo Matías F, Torres Nieto MA.

Rev Clin Esp. 2002 Jul;202(7):405-6. Spanish. No abstract available.

PMID:
12139828
14.

Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma.

García-Avello A, Lorente JA, Cesar-Perez J, García-Frade LJ, Alvarado R, Arévalo JM, Navarro JL, Esteban A.

Thromb Res. 1998 Jan 15;89(2):59-64.

PMID:
9630308
15.

Efficacy of D-dimer and total fibrin degradation products evaluation in suspected pulmonary embolism.

Flores J, Lancha C, Pérez Rodríguez E, García Avello A, Bollo E, García Frade LJ.

Respiration. 1995;62(5):258-62.

PMID:
8560092
16.
17.

[Familial thrombophilia due to resistance to activated protein C].

Cuevas V, Tortosa JI, Rodríguez C, Alonso JM, García Frade LJ.

Sangre (Barc). 1994 Aug;39(4):283-6. Spanish.

PMID:
7985058
18.

[Checking oral anticoagulation in capillary blood].

Navarro JL, César JM, García Frade LJ, Pardo A, Avello AG, Trejo R, Villarrubia J, López J.

Sangre (Barc). 1994 Aug;39(4):257-60. Spanish.

PMID:
7985054
19.

[Hodgkin's disease following non-Hodgkin's lymphoma].

García Frade LJ, Carnero M, Torres M, Fernández C.

Sangre (Barc). 1994 Feb;39(1):60. Spanish. No abstract available.

PMID:
8197523
20.
21.

[Standardization of methods for studying fibrinolysis].

García Frade LJ, Obispo TM.

Sangre (Barc). 1993 Aug;38(4):265-6. Spanish. No abstract available.

PMID:
8235938
22.

[Current status of thrombolysis. The need for coadjuvant antithrombotic therapy].

García Frade LJ, García Avello A.

Rev Clin Esp. 1993 Jun;193(2):88-92. Review. Spanish.

PMID:
8341821
23.

[Analysis of the fibrinolytic response on disseminated intravascular coagulation].

García Frade LJ, García Avello A.

Sangre (Barc). 1993 Jun;38(3):221-4. Review. Spanish. No abstract available.

PMID:
7692611
24.

Time course of hemostatic abnormalities in sepsis and its relation to outcome.

Lorente JA, García-Frade LJ, Landín L, de Pablo R, Torrado C, Renes E, García-Avello A.

Chest. 1993 May;103(5):1536-42.

PMID:
8486040
25.

Plasminogen activator inhibitor-1 levels determine the profibrinolytic response in disseminated intravascular coagulation.

Garciá-Frade LJ, Lorente JA, Garciá-Avello A, de Pablo R, Landín L.

Am J Hematol. 1992 Dec;41(4):303-4. No abstract available.

PMID:
1303660
26.

[Physiopathologic focus of the treatment of consumption coagulopathy in acute non-lymphoblastic leukemia].

García Avello A, García Frade LJ.

Sangre (Barc). 1992 Aug;37(4):279-82. Review. Spanish. No abstract available.

PMID:
1514142
27.

[Hypofibrinolysis in coronary artery disease and predisposing conditions].

Torrado del Puerto MC, García Frade LJ, García Avello A.

Rev Clin Esp. 1992 Jun;191(1):1-2. Spanish. No abstract available.

PMID:
1631353
28.

High plasma urokinase-type plasminogen activator levels are present in patients with acute nonlymphoblastic leukemia.

García Frade LJ, Sureda A, Torrado MC, García Avello A.

Acta Haematol. 1992;88(1):7-10.

PMID:
1414164
29.

A continuous spectrum of hypercoagulability exists in acute nonlymphoblastic leukemia.

Sureda A, García Frade LJ, Torrado MC, García Laraña J, García Avello A.

Acta Haematol. 1992;88(2-3):100-4.

PMID:
1281598
30.

Fibrinolytic parameters and lipoprotein (a) levels in plasma of patients with coronary artery disease.

García Frade LJ, Alvarez JJ, Rayo I, Torrado MC, Lasunción MA, García Avello A, Hernandez A, Marín E.

Thromb Res. 1991 Aug 15;63(4):407-18.

PMID:
1836682
31.

[The white thrombus syndrome and low molecular weight heparin].

García Frade LJ, Gandarias C, Navarro JL.

Sangre (Barc). 1991 Aug;36(4):327-8. Spanish. No abstract available.

PMID:
1663664
32.

[New methods and old concepts in the biological diagnosis of disseminated intravascular coagulation (DIC)].

García Avello A, García Frade LJ.

Sangre (Barc). 1991 Apr;36(2):117-21. Review. Spanish. No abstract available.

PMID:
1830973
33.

[Hemostasis profiles in thrombotic disease].

García Avello A, García Frade LJ, Ortiz P, Torrado MC, Navarro JL.

Rev Clin Esp. 1991 Mar;188(5):227-33. Spanish.

PMID:
1788455
34.

[Lipoprotein-mediated functional changes in the fibrinolytic system in the genesis of atherosclerosis].

García Frade LJ, García Avello A.

Sangre (Barc). 1991 Feb;36(1):25-8. Review. Spanish. No abstract available.

PMID:
1649496
35.

Hereditary hemorrhagic telangiectasia: analysis of platelet aggregation and fibrinolytic system in seven patients.

Sureda A, César J, García Frade LJ, García Avello A, Fernández Fuertes I, Navarro JL.

Acta Haematol. 1991;85(3):119-23.

PMID:
1710408
36.

[Value of D-dimers in the diagnosis of pulmonary thromboembolism].

Sureda A, Pascual J, Garcia Frade LJ.

Presse Med. 1990 Dec 22-29;19(44):2038. French. No abstract available.

PMID:
2148625
37.

[New options in the prevention and treatment of thromboembolic disease: low-molecular-weight heparins].

Sureda A, García Frade LJ, Navarro JL.

Sangre (Barc). 1990 Oct;35(5):389-96. Review. Spanish. No abstract available.

PMID:
1963241
38.

Hypofibrinolysis associated with vasculopathy in non insulin dependent diabetes mellitus.

García Frade LJ, de la Calle H, Torrado MC, Lara JI, Cuellar L, García Avello A.

Thromb Res. 1990 Jul 1;59(1):51-9.

PMID:
2119076
39.

Thrombus age and tissue plasminogen activator mediated thrombolysis in rats.

Loren M, García Frade LJ, Torrado MC, Navarro JL.

Thromb Res. 1989 Oct 1;56(1):67-75.

PMID:
2512687
40.

[Thrombolytic agents: efficacy in relation to evolution time and dose].

García Frade LJ, Torrado MC, Loren M, Navarro JL.

Rev Clin Esp. 1989 Feb;184(2):75-9. Spanish.

PMID:
2502822
41.

[Increase in the fibrinolytic activity in patients with hyperlipoproteinemias type IV treated with bezafibrate].

Obispo TM, García Fradé LJ, García Avelló A, César J, Sastre A, Navarro JL.

Rev Clin Esp. 1988 Feb;182(3):151-4. Spanish. No abstract available.

PMID:
3368592
42.

Changes in fibrinolysis in the intensive care patient.

García Frade LJ, Landin L, Avello AG, Martin Yerro J, Navarro JL, Creighton LJ, Gaffney PJ.

Thromb Res. 1987 Sep 1;47(5):593-9.

PMID:
3672437
43.

Diabetes mellitus as a hypercoagulable state: its relationship with fibrin fragments and vascular damage.

García Frade LJ, de la Calle H, Alava I, Navarro JL, Creighton LJ, Gaffney PJ.

Thromb Res. 1987 Sep 1;47(5):533-40.

PMID:
3118498
44.

Bioavailability in rats of human recombinant tissue plasminogen activator after subcutaneous and intramuscular injection.

Garcia Frade LJ, Poole S, Hanley S, Creighton LJ, Curtis AD, Gaffney PJ.

Thromb Haemost. 1986 Dec 15;56(3):299-301.

PMID:
3105106
45.

[Purification of fibronectin using gelatin derivatives].

Tolón RM, Obispo T, Alava I, Navarro JL, García-Frade LJ.

Rev Esp Fisiol. 1986 Dec;42(4):535-41. Spanish.

PMID:
3563080
46.

[Plasma fibronectin in acute myeloid leukemia].

García Frade LJ, García Avello A, Obispo T, Alava I, Odriozola J, Cesar J, Pardo A, Navarro JL.

Sangre (Barc). 1984;29(4-A):376-83. Spanish. No abstract available.

PMID:
6594781
47.

[Optical and ultrastructure study of the effect of Serratia marcescens endotoxin at the hepatic level].

García Frade LJ, Llanes Menéndez F, López Muñiz A, Bengoechea González ME, Alvarez Arenal A.

Rev Clin Esp. 1983 Oct 31;171(2):107-10. Spanish. No abstract available.

PMID:
6361923

Supplemental Content

Loading ...
Support Center